Recombinant antibodies such as nanobodies are progressively demonstrating to be a valid
alternative to conventional monoclonal antibodies also for clinical applications. Furthermore …

Background: Ovarian cancer is the sixth most common cause of cancer-related death in the
UK amongst women. Ovarian cancer presents particular challenges for general practitioners …

Objective The aim of this study was to build a nomogram based on clinical markers for
predicting the malignancy of ovarian tumors (OTs). Method A total of 1,268 patients …

Materials and methods. 119 patients with ovarian cancer of the IIIC stage were involved into
the study from 2013 to 2020 and they were treated at the University Clinic of Odessa …

Background Epithelial ovarian cancer (EOC) is the main subtype of ovarian cancer and
shows an aggressive phenotype and poor prognosis. Neuronal pentraxin II (NPTX2) is a …

Background Timely diagnosis of bladder and kidney cancer is key to improving clinical
outcomes. Given the challenges of early diagnosis, models incorporating clinical symptoms …

Objectives Assessment of age, sex and smoking-specific risk of cancer diagnosis and non-
cancer mortality following primary care consultation for 15 new-onset symptoms. Methods …

To investigate the function and possible mechanism of miR-92a in malignant behaviors such
as paclitaxel resistance in ovarian cancer (OC) cells. The miR-92a and PTEN expression …

Background Most prior studies investigating the risk of ovarian malignancy algorithm
(ROMA) with cancer antigen 125 (CA125) and human epididymis protein 4 (HE4) have …

Gynecological malignancy remains a prevalent cause of mortality among women. Chronic
cancer pain, as a severe complication of malignancy and its therapies, accounts for a …